logo-loader
RNS
viewCircassia Group PLC

Circassia Pharma Plc - Change of Name Effective

RNS Number : 6507L
Circassia Pharmaceuticals Plc
01 May 2020
 

Change of Name Effective

Oxford, UK - 1 May 2020: Circassia Group plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today confirms that, further to the announcement of 30 April 2020, its change of name has taken effect. The Company's TIDM remains CIR and the Company's website address continues to be www.circassia.com.

 

Contacts

 

Circassia

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

 

c/o Peel Hunt

 

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Oliver Jackson

 

Tel: +44 (0) 20 7418 8900

 

finnCap (Joint Broker)

Geoff Nash / Alice Lane

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

Tel: +44 (0) 20 7260 1000

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
CANFIFFAETILIII

Quick facts: Circassia Group PLC

Price: 25.5

Market: LSE
Market Cap: £96.11 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE